Conley Chee
CIK: 0001883804
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syros Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Nov 18, 2024SYRS
Syros Pharmaceuticals, Inc.
Sale(S)Direct134.8K shares at avg. $0.20$27K - Oct 31, 2024SYRS
Syros Pharmaceuticals, Inc.
Exercise(M)Direct17K shares- - Oct 31, 2024SYRS
Syros Pharmaceuticals, Inc.
Tax Payment(F)Direct8.7K shares at avg. $2.09$18K - Sep 11, 2024SYRS
Syros Pharmaceuticals, Inc.
Purchase(P)Direct50K shares at avg. $1.71$85K - Sep 10, 2024SYRS
Syros Pharmaceuticals, Inc.
Purchase(P)Direct50K shares at avg. $1.51$75K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 18, 2024 | SYRS Syros Pharmaceuticals, Inc. | Sale(S) | 134,797 | $0.20 | $26,932 | Direct |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | Exercise(M) | 17,000 | - | $0 | Direct |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | Tax Payment(F) | 8,707 | $2.09 | $18,198 | Direct |
| Sep 11, 2024 | SYRS Syros Pharmaceuticals, Inc. | Purchase(P) | 50,000 | $1.71 | $85,420 | Direct |
| Sep 10, 2024 | SYRS Syros Pharmaceuticals, Inc. | Purchase(P) | 50,000 | $1.51 | $75,260 | Direct |
1-5 of 5 transactions
Conley Chee files insider reports with the SEC as President & CEO of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 5 reported Form 4/5 transactions by Conley Chee since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 18, 2024.
About Chee Conley
Chee Conley (SEC CIK 0001883804) files insider reports with the SEC as President & CEO of Syros Pharmaceuticals, Inc. (SYRS).
Signal8 holds 3 ownership filings by Chee Conley, all Form 4s, filed between Sep 12, 2024 and Nov 20, 2024. Those filings report 5 transactions, from Sep 10, 2024 to Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Chee Conley's filings is in CAMBRIDGE, MA.
Recent filings by Chee Conley
- Nov 18, 2024: Open-market sale of SYRS shares (Form 4, code S).
- Oct 31, 2024: Option exercise of SYRS shares (Form 4, code M).
- Oct 31, 2024: Tax withholding of SYRS shares (Form 4, code F).
- Sep 11, 2024: Open-market purchase of SYRS shares (Form 4, code P).
- Sep 10, 2024: Open-market purchase of SYRS shares (Form 4, code P).
Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)
- Simonian Nancy A, Director
- Stephens Kristin, Chief Development Officer
- Roth David, Chief Medical Officer
- Quirk Gerald E, Chief Legal & Compliance Offic
- Haas Jason, Chief Financial Officer
- AKKARAJU SRINIVAS, Director